Find a TenderAwardedContract details notice

Published 24 Oct 2025, 12:45 BST

Official UK procurement notice

NHS National Framework for Transition Products (Nintedanib and Dalbavancin)

Official notice

Authority: NHS England (Central government)

Framework agreementGoodsOpen procedureAbove thresholdSME suitable

Sectors: Medical Devices & Pharma (33) Delivery: North East (UKC)North West (UKD)East Midlands (UKF)

+4 more

West Midlands (UKG)East of England (UKH)South East (UKJ)South West (UKK)

Framework ceiling (notional)£115,756,000framework ceiling, not attributable revenue · 1 value update

Submissions closed 28 Jan 2026awarded 25 Feb 2026

Award (standstill) to ACCORD-UK LTD +6 more

Framework period 1 yr 5 moends 30 Sept 2027 · up to 30 Sept 2029 with extensions · starts 1 May 2026

What is being bought

Published requirement description

Project title: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) commencing 1st May 2026

Offer reference number: CM/TNS/25/5736

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.

CM/TNS/25/5736 Nintedanib and Dalbavancin

Lot 1 DLN/DNW: 01/05/2026 to 30/09/2027 (17 months)

Lot 2 DLS/DNE: 01/05/2026 to 31/05/2027 (13 months)

Lot 3 DCE/DSW: 01/05/2026 to 31/01/2027 (9 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

CPV: Pharmaceutical products

How this framework works

From the published notice

Type: Closed framework
Call-offs: every call-off is a further competition among the appointed suppliers
Bids received: 14 bids received · 9 suppliers appointed
Framework period: 1 yr 5 mo · up to 3 yrs 5 mo from 1 May 2026

Who may buy through it

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

Published description of the framework

Please refer to the ITO Documents for the Operation Description

The lotProcurement structure

single lot · value published

Lot #1AwardedRenewal 1 yr 5 moSMEPublished value£115,756,000

Contract period: 1 May 2026 – 30 Sept 2027 (1 yr 5 mo) · up to 30 Sept 2029 with extensionsValue: £115,756,000 exc. VAT · £138,907,200 inc. VAT

Delivery: North East, North West, East Midlands, West Midlands, East of England, South East, South WestEligibility: SME eligible

Extensions: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months

33600000 Pharmaceutical products

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more

How bids were scored

Price: 100%

Published sub-criteria (1)

Price is not the only award criterion: 100%

Published award criteria (1)

Price is not the only award criterion

What this means for your bid

Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
“NHS National Framework for Transition Products (Nintedanib and…” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record

Procedure method: Open procedure
Legal basis: UKPGA · 2023/54 Procurement Act 2023
Procurement category: Goods
Notice status: Awarded
Procurement threshold: Above threshold (FTS publication)
Regulatory regime: Standard
Commercial structure: Framework agreement
Who may use this agreement: Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Competition type: Competitive procedure
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 24 Oct 2025, 12:45 BST
Last source update: 24 Apr 2026, 09:59 BST
Award evaluation window: Submission end – 25 Feb 2026
Authority reference: C397096
FTS notice number: 2025/S 000-084554
Latest notice: Contract details notice (UK7)
Classification (CPV): Pharmaceutical products
Delivery area: North East (UKC)North West (UKD)East Midlands (UKF)West Midlands (UKG)East of England (UKH)South East (UKJ)South West (UKK)
Official registry OCID: ocds-h6vhtk-05d361 Find a Tender

How it was run

Official notice

Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis

Supplier login requiredElectronic submission allowedLanguage: EN

Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated

Appointment period ends: 28 Jan 2026, 13:00 GMT
Clarification deadline: 21 Jan 2026
Submission channel: Official e-sourcing portal
Electronic submission: Allowed
Accepted languages: en

Detailed submission instructions & authority contactsFrom official release

The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗

Additional info obtained from the abovementioned address

Tenders must be submitted to the abovementioned address

Timeline

24 Oct 2025 → 1 May 2026 · 11 dates

Planning notice published367 days ago
24 Oct 2025, 12:45 BST
Market engagement339 days ago
20 Nov 2025, 23:59 GMT
NHS England is seeking to engage with suppliers that are planning to launch any of the molecules that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact [email protected] or [email protected] to register your interest in tendering for this framework. Please indicate which products your company is planning to bring to market in your response.
Next notice expected312 days ago
17 Dec 2025, 23:59 GMT
Tender notice published312 days ago
18 Dec 2025, 15:49 GMT
Clarification questions by278 days ago
21 Jan 2026
Admission / appointment period ends271 days ago · period end, not a bid countdown
28 Jan 2026, 13:00 GMT
Assessment summaries sent243 days ago
25 Feb 2026
Award decision expected by242 days ago
25 Feb 2026, 23:59 GMT
Standstill ends233 days ago
6 Mar 2026, 23:59 GMT
Latest notice published185 days ago
24 Apr 2026, 09:59 BST
Contract starts178 days ago
1 May 2026, 00:00 BST

Notice history

10 events · 4 releases on Find a Tender · since 24 Oct 2025

Preliminary market engagement notice published
24 Oct 2025, 12:45 BST
UK2
Tender notice published
18 Dec 2025, 15:49 GMT
UK4
Published value updated to £115,756,000
18 Dec 2025, 15:49 GMT
was £88,500,000
Status changed to active
18 Dec 2025, 15:49 GMT
Procurement method changed
18 Dec 2025, 15:49 GMT
Deadline published: 28 Jan 2026, 13:00 GMT
18 Dec 2025, 15:49 GMT
Contract award notice published
25 Feb 2026, 13:10 GMT
UK6
Status changed to complete
25 Feb 2026, 13:10 GMT
Contract signature expected
20 Mar 2026, 23:59 GMT
scheduled
Contract details notice published
24 Apr 2026, 09:59 BST
UK7

Routine re-releases (4)

2025-10: 1 release · 24 Oct 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Suppliers appointed 92 awards · see the list ↓

Bids received 144 from SMEs

Named bidders 14published on the award notice

Contracts signed 1latest 27 Mar 2026

Awarded to	Value	Date	Status
ACCORD-UK LTD, Baxter Healthcare Ltd, Celix Pharma Ltd., Dr Reddy's Laboratories (UK) Ltd, Glenmark Pharmaceuticals Europe Ltd, Wockhardt UK Limited +1 moreLot 1 - CM/TNS/25/5736 Nintedanib and Dalbavancin1 May 2026 – 30 Sept 2027 · up to 30 Sept 2029Extensions: An option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.	£14,758,000	25 Feb 2026standstill to 6 Mar 2026	Standstill

Contracts

Lot 1 - CM/TNS/25/5736 Nintedanib and Dalbavancin
Signed
27 Mar 2026
Value
£14,758,000
Period
1 May 2026 – 30 Sept 2027 · up to 30 Sept 2029 with extensions
Status
active
Extensions
An option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
14final-stage tenders	4	0	—

Who bid

wonCELIX PHARMA LTD · East of England
wonACCORD-UK LTD · South West England
wonBaxter Healthcare Ltd · South East England
wonDR REDDY'S LABORATORIES (UK) LIMITED · East of England
wonGlenmark Pharmaceuticals Europe Limited · East of England
wonWOCKHARDT UK LIMITED · Wales (Cymru)
wonZENTIVA PHARMA UK LIMITED · South East England
did not winCIPLA (EU) LIMITED · Greater London
did not winMERCURY PHARMACEUTICALS LIMITED · Greater London
did not winMILPHARM LIMITED · Greater London
did not winREIG JOFRE UK LIMITED · South West England
did not winSANDOZ LIMITED · South East England
did not winTEVA UK LIMITED · Yorkshire and the Humber
did not winTILLOMED LABORATORIES LIMITED · East of England

Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.

Contracting authority & participating public bodies

NHS England

Contracting authorityPublic authority - central government GB-PPON: PDPT-3135-BWWY Wellington House, 133-135 Waterloo Rd, London, London, SE1 8UGContact name, email

Framework contractors & participating bidders

14 commercial parties on the notice · 9 awarded

ACCORD-UK LTDFramework contractorGB-COH: 00079585 Whiddon Valley, Devon, South West, EX32 8NSContact email
Baxter Healthcare LtdFramework contractorGB-COH: 00461365 Spur A, 2nd Floor, Reading International Business Park, Reading, South East, RG2 6DHContact email
CELIX PHARMA LTdFramework contractorGB-COH: 12474195 1st Floor, Building 2, Croxley Business Park, Watford, East of England, WD18 8YAContact email
CIPLA (EU) LIMITEDBidder / tendererGB-COH: 04513292 3RD FLOOR, LONDON, London, W14 8NS
DR REDDY'S LABORATORIES (UK) LIMITEDFramework contractorGB-COH: 01729064 410, Cambridge Science Park Milton Rd, Milton, Cambridge, East of England, CB4 0PEContact email
Glenmark Pharmaceuticals Europe LimitedFramework contractorGB-COH: 05040260 Building 2, Croxley Green Business Park,, Watford, East of England, WD18 8YAContact email
MERCURY PHARMACEUTICALS LIMITEDBidder / tendererGB-COH: 02619880 Dashwood House, London, London, EC2M 1QS
MILPHARM LIMITEDFramework contractorGB-COH: 03354124 Ares Block Odyssey Business Park, South Ruislip, London, HA4 6QDContact email
REIG JOFRE UK LIMITEDFramework contractorGB-COH: 09301085 Follaton House, Totnes, South West, TQ9 5NEContact email
SANDOZ LIMITEDBidder / tendererGB-COH: 01547204 Maxis 1, Western Road, Bracknell, South East, RG12 1RF

Show 4 more suppliers

TEVA UK LIMITEDBidder / tendererGB-COH: 00302461 Ridings Point, Castleford, Yorkshire & Humber, WF10 5HX
TILLOMED LABORATORIES LIMITEDBidder / tendererGB-COH: 02544103 220 Butterfield, Luton, East of England, LU2 8DL
WOCKHARDT UK LIMITEDFramework contractorGB-COH: 05835570 Ash Road North, Wrexham, Wales, LL13 9UFContact email
ZENTIVA PHARMA UK LIMITEDFramework contractorGB-COH: 02158996 First Floor, College Rd, Guildford, South East, GU1 4QBContact email

Official documents & specifications (17)

Official links; attachments are not copied

Tender pack and attachments

Bidding documents and specifications tenderBidding documents and specificationsXLSXDocument No. 10 - C386886 - Requirement Section 1. Procurement Specific Questionnaire (PSQ) CM-TNS-25-5736
Bidding documents and specifications tenderBidding documents and specificationsxmlDocument No. 05a - Selectt offer schedule - CM-TNS-25-5736
Bidding documents and specifications tenderBidding documents and specificationsDOCXDocument No. 02 - Terms of offer CM-TNS-25-5736
Bidding documents and specifications tenderBidding documents and specificationsDOCXDocument No. 04 - Quality Assurance Process CM-TNS-25-5736
Bidding documents and specifications tenderBidding documents and specificationsDOCXDocument No. 05 - Selectt offer schedule instructions CM-TNS-25-5736
Bidding documents and specifications tenderBidding documents and specificationsDOCXDocument No. 03 - Framework Agreement and Terms and Conditions CM-TNS-25-5736
Bidding documents and specifications tenderBidding documents and specificationsDOCXDocument No. 06 - Form of offer CM-TNS-25-5736
Bidding documents and specifications tenderBidding documents and specificationsXLSXDocument No. 08 - Confidential information schedule CM-TNS-25-5736

Show 5 more documents

Bidding documents and specifications tenderBidding documents and specificationsXLSXDocument No. 09 - Pharmacy Purchasing Points List - CM-TNS-25-5736
Signed contract contractSigned contractPDFCONTRACT COPY UK7 Contract Details Document CM-TNS-25-5736
Bidding documents and specifications tenderBidding documents and specificationsXLSXDocument No. 05b - Tender Product Listing and Usage - CM-TNS-25-5736
Bidding documents and specifications tenderBidding documents and specificationsDOCXDocument No. 01 - Invitation to offer covering letter CM-TNS-25-5736
Bidding documents and specifications tenderBidding documents and specificationsDOCXDocument No. 07 - Quality control technical sheet CM-TNS-25-5736

Notices published for this procedure

Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender24 Apr 2026, 09:59 BST
Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender25 Feb 2026, 13:10 GMT
Tender notice tenderTender noticeUK4Tender notice on Find a Tender18 Dec 2025, 15:49 GMT
Preliminary market engagement notice planningPreliminary market engagement noticeUK2Preliminary market engagement notice on Find a Tender24 Oct 2025, 12:45 BST